Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.

Source:http://linkedlifedata.com/resource/pubmed/id/18197434

Download in:

View as

General Info

PMID
18197434